Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04529447
Other study ID # JMA-CT-2020-01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 10, 2020
Est. completion date August 10, 2020

Study information

Verified date July 2022
Source Jaseng Hospital of Korean Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objectives of this study are to report the response strategy to prevent COVID-19 spread implemented at a Korean medicine hospital, and the satisfaction survey results regarding its preventive measures.


Description:

The objectives of this study are (1) to report the response strategy to prevent COVID-19 spread implemented at a Korean medicine hospital situated in Seoul, Korea, (2) to describe patient visit trends compared to the number of confirmed COVID-19 cases during the COVID-19 peak in February - April 2020, and (3) to provide results of a satisfaction survey regarding its preventive measures.


Recruitment information / eligibility

Status Completed
Enrollment 485
Est. completion date August 10, 2020
Est. primary completion date August 10, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Inpatients hospitalized at Jaseng Hospital of Korean medicine during March 23-25, 2020 - Outpatients visiting Jaseng Hospital of Korean medicine during March 23-25, 2020 Exclusion Criteria: - Visitors visiting Jaseng Hospital of Korean medicine during March 23-25, 2020 for purposes other than treatment

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Survey
The patient satisfaction survey consisted of 8 items, including 7 Likert scale questions and 1 multiple choice question.

Locations

Country Name City State
Korea, Republic of Jaseng Hospital of Korean Medicine Seoul

Sponsors (1)

Lead Sponsor Collaborator
Jaseng Hospital of Korean Medicine

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Satisfactory service regarding hospital response to COVID-19 Multiple choice question on satisfactory service regarding hospital response to COVID-19, if any Baseline (time of current visit)
Secondary Feelings of apprehension regarding hospital visits Likert scale question on level of feelings of apprehension before hospital visits due to COVID-19 Baseline (time of current visit)
Secondary Medical staff wearing of facial masks and hand hygiene Likert scale question on level of maintenance of wearing of facial masks and hand hygiene in medical staff Baseline (time of current visit)
Secondary Cleanliness and sterilization of hospital facilities Likert scale question on level of cleanliness and sterilization of hospital facilities with regard to COVID-19 spread prevention Baseline (time of current visit)
Secondary Convenience and accessibility of hand sanitizers Likert scale question on level of convenience and accessibility of hand sanitizers Baseline (time of current visit)
Secondary Helpfulness and readability of posters and stand-up banners Likert scale question on level of helpfulness and readability of posters and stand-up banners with COVID-19 information in the hospital Baseline (time of current visit)
Secondary Satisfaction with hospital safety measures for COVID-19 Likert scale question on level of satisfaction with hospital safety measures for COVID-19 Baseline (time of current visit)
Secondary Recommendation of hospital to friends and family Likert scale question on level of recommendation of this hospital to friends and family concerned with visiting hospitals due to COVID-19 Baseline (time of current visit)
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Active, not recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3